A team of researchers from George Institute for Global Health developed a new formulation to treat blood pressure. After the latest clinical trials, researchers revealed the effectiveness and safety of the innovative drug, which combines in low doses three drugs that are currently used to treat hypertension: telmisartan, amlodipine and chlorthalidone. This formulation promises to be much more efficient, without side effects and will eliminate some of the inconveniences related to conventional treatments.
Fuente: www.medicalnewstoday.com